Related Experiment Videos
Clinical characterization of imuthiol.
Methods and Findings in Experimental and Clinical Pharmacology
|January 1, 1986
Summary
Imuthiol effectively recruits and regulates T cells, restoring immune function. This immunomodulator shows promise in treating T-cell deficiencies, leading to cures in various conditions.
Area of Science:
- Immunology
- Pharmacology
Background:
- T-cell deficiencies and dysfunction can underlie various chronic diseases.
- Restoring T-cell function is a therapeutic goal for immune-related conditions.
Purpose of the Study:
- To evaluate the efficacy of Imuthiol in modulating T-cell activity.
- To assess the therapeutic potential of Imuthiol in conditions associated with T-cell dysfunction.
Main Methods:
- Phase III clinical studies were conducted.
- Immune function parameters were monitored.
- Clinical outcomes in patients with chronic bronchitis, bronchiectasis, rheumatoid arthritis, tuberculosis, and elderly chronic infections were assessed.
Main Results:
- Imuthiol demonstrated T-cell recruitment and regulation.
- Immune functions were restored to normal or near-normal levels in chronic bronchitis and bronchiectasis.
- Successful treatment outcomes, including cures, were observed in rheumatoid arthritis, tuberculosis, and chronic infections in the elderly.
Conclusions:
- Imuthiol is a safe and effective immunomodulatory agent.
- The drug is beneficial for treating diseases stemming from T-cell deficiency or dysfunction.
- Imuthiol offers a therapeutic strategy for a range of immune-related disorders.